TissueGen, Inc.
11Patents
5Active
11Granted
43Portfolio score
Filing activity: Jun 30, 1999 → Nov 9, 2021 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6315992A | Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-.beta.-1 | Human Necessities | 31 | Expired |
| US8672996B2 | Self-expanding medical device | Human Necessities | 6 | Active |
| US7005127B2 | Mixed-cell gene therapy | Chemistry; Metallurgy | 5 | Expired |
| US7431922B2 | Bioadhesive directed somatic cell therapy | Human Necessities | 2 | Expired |
| US6797703B1 | Gene therapy using TGF-&bgr; | Human Necessities | 2 | Expired |
| US7282200B2 | Mixed-cell gene therapy | Chemistry; Metallurgy | 2 | Expired |
| US7338655B1 | Gene therapy using TGF-β | Human Necessities | 1 | Expired |
| US11197905B2 | Methods and compositions for maintaining the conformation and structural integrity of biomolecules | Chemistry; Metallurgy | 1 | Active |
| US10363281B2 | Methods and compositions for maintaining the conformation and structural integrity of biomolecules | Chemistry; Metallurgy | 1 | Active |
| US11007296B2 | Drug-eluting self-retaining sutures and methods relating thereto | Human Necessities | 0 | Active |
| US12121560B2 | Methods and compositions for maintaining the conformation and structural integrity of biomolecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.